Authors
Latest:
Treatment of metastatic renal cell carcinoma: What can we offer?To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.
Latest:
Treatment of metastatic renal cell carcinoma: What can we offer?To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.
Latest:
No business as usual post COVID? Maybe a good thing"Professionally, I am mentally and logistically preparing for a different medical environment when we all return from isolation. I doubt it will ever be business as usual again," writes Bradley A. Erickson, MD, MS.
Latest:
Stones, stents, sepsis, and the need for some common sense"If we can’t get the emergency rooms physicians to apply a bit of common sense to medicine, maybe we should require that they all have a ureteral stent placed for a few weeks during their residency so that they have a better idea of what these patients go through," writes Henry Rosevear, MD.
Latest:
Letter: IMRT ownership study methodology unsound"Utilization analysis of health care resources must be free of bias, methodologically sound, and relevant to current practice," writes Deepak A. Kapoor, MD.
Latest:
How to prevent stone formation in patients with metabolic syndromeThis article examines the relationship between the metabolic syndrome and kidney stone disease. We explain elements of the metabolic workup and practical strategies for prevention and management of stones in patients with the metabolic syndrome.
Latest:
Best of AUA 2015: PCa surveillance, surgical controversies create buzzUrology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas-an information-packed, condensed summary of the top papers and presentations.
Latest:
Software systems begin to merge business, medical dataAn important trend is emerging in the arena of practice management systems,and industry observers say urologists would be well advised to keep up todate on it.
Latest:
Mirabegron may improve erectile dysfunction in men with overactive bladder symptomsThe findings support continued investigation of the safety and efficacy of mirabegron in men with OAB and concurrent ED, says study author Arthur L. Burnett, II, MD, MBA.
Latest:
Immunotherapy for bladder Ca: What urologists need to knowPeter Black, MD, discusses which patients are currently eligible for immunotherapy, how the indications are likely to expand, some of the common side effects of immunotherapy and their incidence, and the availability of tools to determine which patients are suitable candidates for treatment.
Latest:
Nocturia: An update on diagnosis and treatmentIn this video, Alan J. Wein, MD, PhD, discusses recent developments in the management of nocturia, including a new FDA-approved agent; underlying causes; and the role of a voiding diary in patient care.
Latest:
Tips for integrating APPs into your practiceAnne E. Calvaresi, DNP, CRNP, RNFA, also discusses best practices that urologists and APPs can follow to ensure they work together well as a team and offers her opinion on the controversy surrounding the use of APPs for performing certain urologic procedures.
Latest:
Unmet Needs Surrounding the Treatment of Prostate CancerPaul M. Yonover, MD, FACS, offers closing thoughts on unmet needs and clinical challenges surrounding the treatment of prostate cancer.
Latest:
Hydrogel spacer use during prostate RT: Community experienceRecent data support the product’s use in protecting organs at risk for radiation exposure.
Latest:
EP. 15: Subsequent Treatment Considerations for Patients with Unsatisfactory Responses to Third-Line Therapy for OABExperts close their panel on OAB by identifying treatment pathways for patients who have an unsatisfactory response to third-line therapy.
Latest:
Laser vaginal rejuvenation: What urologists need to know"The world of laser vaginal rejuvenation is fast paced, with new companies adding a laser platform nearly each month," write Jessica DeLong, MD, and Jennifer Miles-Thomas, MD.
Latest:
Depression and suicide in men: Identifying the riskThis article discusses the risk of depression and suicide in men, focusing on increased risk in men with genitourinary cancer and other urologic conditions.
Latest:
Should your practice consider a MIPS virtual group?“Urology practices that are struggling to achieve payment increases and bonuses under MIPS for 2017 and 2018 may reap some strategic benefits from taking the lead in forming virtual groups in subsequent years,” according to Rick Rutherford, CMPE.
Latest:
A Look Into The Future of PSMA-Targeted Therapies in Prostate CancerPanelists review the recent FDA approval of the PSMA-targeted therapy Lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer and discuss additional settings in which it, and other PSMA-targeted treatments, might be used in the future.
Latest:
Unintentional injury in men: Trends and risk reductionUrology visits afford a unique opportunity to discuss falls, drug use, and work accidents.
Latest:
Saw Palmetto Extracts in BPH and LUTS: Practical Advice on Patient EducationClosing out his discussion on saw palmetto extracts in benign prostatic hyperplasia and lower urinary tract symptoms, Bilal Chughtai, MD, shares practical advice for physicians.
Latest:
How wearable devices may optimize post-surgery outcomesRecent studies point to the significant potential activity trackers hold in urology.
Latest:
How wearable devices may optimize post-surgery outcomesRecent studies point to the significant potential activity trackers hold in urology.
Latest:
Right to try legislation: Questions surround its substanceA bill commonly known as “Right to Try,” or S.204, appears to be a step in the right direction for expanding access to treatment for terminally ill patients who have exhausted all other options.
Latest:
Challenging case: A young woman presenting with rapid weight gainAn 18-year-old previously healthy collegiate athlete presented to the emergency room with a rapid weight gain of 20 pounds during the previous 2 months. She complained of significant fatigue and irregular menstrual periods.
Latest:
Can finger length predict prostate cancer risk?Christian Lawlor, BSc, Karl Miller, BSc, and David Albala, MD, explore the possible correlation.
Latest:
Can finger length predict prostate cancer risk?Christian Lawlor, BSc, Karl Miller, BSc, and David Albala, MD, explore the possible correlation.
Latest:
Practical Guidance for Prostate Cancer Imaging: PSMA-PET Scans and Patient SelectionDavid Albala, MD, shares closing advice on using PSMA-PET scans in prostate cancer management and making informed patient selection decisions based on guidelines and practical insights.
Latest:
The argument for surgical management of high-risk prostate cancerRadical prostatectomy can provide superior survival compared with radiation therapy, especially in young and healthy men.
Latest:
The argument for surgical management of high-risk prostate cancerRadical prostatectomy can provide superior survival compared with radiation therapy, especially in young and healthy men.
